コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rgens (e.g., food allergies and eosinophilic gastrointestinal disorders).
2 Irritable bowel syndrome (IBS) is a common gastrointestinal disorder.
3 bowel syndrome (IBS) is a chronic functional gastrointestinal disorder.
4 ategory of abdominal pain-related functional gastrointestinal disorder.
5 e potential utility of microbe discovery for gastrointestinal disorders.
6 ted with visceral hyperalgesia in functional gastrointestinal disorders.
7 g gut microbiota and reduces weaning-related gastrointestinal disorders.
8 evention and treatment of a variety of human gastrointestinal disorders.
9 in children with pain-predominant functional gastrointestinal disorders.
10 regarding the use of rifaximin for different gastrointestinal disorders.
11 f distress in adult patients with functional gastrointestinal disorders.
12 ore than 30 other countries for a variety of gastrointestinal disorders.
13 d important in pain perception in functional gastrointestinal disorders.
14 elationship to reflux disease and functional gastrointestinal disorders.
15 derstanding of both organic and 'functional' gastrointestinal disorders.
16 sensitivity, is often observed in functional gastrointestinal disorders.
17 ic procedures used to deal with a variety of gastrointestinal disorders.
18 derstanding of both organic and 'functional' gastrointestinal disorders.
19 or the treatment of patients with functional gastrointestinal disorders.
20 tailor treatment to children with functional gastrointestinal disorders.
21 armacology of medications used in functional gastrointestinal disorders.
22 derstanding of both organic and 'functional' gastrointestinal disorders.
23 enteric pathogen responsible for a number of gastrointestinal disorders.
24 ologies associated with diverse vascular and gastrointestinal disorders.
25 important part of therapy for several common gastrointestinal disorders.
26 e mediation of both visceral nociception and gastrointestinal disorders.
27 from this site may play a role in recurrent gastrointestinal disorders.
28 bers of adverse experiences, including upper-gastrointestinal disorders.
29 athophysiological research in the functional gastrointestinal disorders.
30 and gut and could lead to new treatments for gastrointestinal disorders.
31 s with each other and the host in functional gastrointestinal disorders.
32 vity and abdominal pain associated with many gastrointestinal disorders.
33 ed to the trial medication, seven (50%) were gastrointestinal disorders.
34 uggests that it might contribute to neonatal gastrointestinal disorders.
35 to understand dysfunctions in the functional gastrointestinal disorders.
36 d may explain comorbid conditions, including gastrointestinal disorders.
37 known about the effects of air pollution on gastrointestinal disorders.
38 < .001), and 0 of 8 patients with unrelated gastrointestinal disorders.
39 ole on gastric emptying (GE) in a variety of gastrointestinal disorders.
40 inflammatory bowel disease and in functional gastrointestinal disorders.
41 cial role in the diagnosis and management of gastrointestinal disorders.
42 e (IBS) is one of the most common functional gastrointestinal disorders.
43 across a diverse array of both affective and gastrointestinal disorders.
44 cents with abdominal pain-related functional gastrointestinal disorders.
45 he 2 most common conditions among functional gastrointestinal disorders.
46 um of 1 year) to assess for incident chronic gastrointestinal disorders.
47 he bacterial microbiota in dogs with various gastrointestinal disorders.
48 order (OR 2.72, 95% CI 1.09-6.81, p=0.0323), gastrointestinal disorders (1.94, 1.03-3.65, p=0.0390),
51 ssions for nonpulmonary diagnoses, including gastrointestinal disorders (14 admissions), cardiovascul
52 verse events (p=0.122); the most common were gastrointestinal disorders (174 [68%] vs 180 [69%]) and
53 12 [8%]), diarrhoea (16 [10%] vs four [3%]), gastrointestinal disorders (18 [11%] vs 12 [8%]), and ha
55 vs. 47%), as were the rates of grade 3 or 4 gastrointestinal disorders (28% vs. 7%) and infections (
56 eight patients [28%] in the placebo group), gastrointestinal disorders (34 [61%] vs eight [28%]), in
57 ronic constipation is a prevalent functional gastrointestinal disorder accompanied with intestinal dy
60 on adverse events related to plerixafor were gastrointestinal disorders and injection site reactions.
61 tly been more used for patients with diffuse gastrointestinal disorders and preserved hepatic functio
62 nths of life reduced the onset of functional gastrointestinal disorders and reduced private and publi
63 ovide insights into the pathogenesis of many gastrointestinal disorders and the development of therap
65 osive gastrointestinal disorders, nonerosive gastrointestinal disorders, and disorders involving incr
66 disorders in understanding adult functional gastrointestinal disorders, and encouraging clinical and
67 mune diseases, such as rheumatoid arthritis, gastrointestinal disorders, and myocardial ischemia.
69 processes, including infections, asthma, and gastrointestinal disorders, and new data concerning gene
70 Rome III "abdominal pain related functional gastrointestinal disorders" (AP-FGID) has been changed t
76 mucosal barrier, and secretion in functional gastrointestinal disorders as well as effects of food, m
78 his group included patients with symptomatic gastrointestinal disorders as well as nonsymptomatic vol
80 is an enteropathogenic bacterium that causes gastrointestinal disorders, as well as extraintestinal m
81 inhibitors may provide novel treatments for gastrointestinal disorders associated with dysregulation
82 ease is one of the most prevalent autoimmune gastrointestinal disorders, but as the case of Ms J illu
83 in is used to treat patients with functional gastrointestinal disorders, but little is known about it
84 bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal dis
85 Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pai
86 ital lactase deficiency is an extremely rare gastrointestinal disorder characterized by neonatal-onse
87 rritable bowel syndrome (PI-IBS) is a common gastrointestinal disorder characterized by persistent ab
90 crobiota has also been studied in functional gastrointestinal disorders; data remain inconclusive.
91 Functional dyspepsia (FD) is a functional gastrointestinal disorder diagnosed by symptom-based cri
92 the world with fecal incontinence and other gastrointestinal disorders, educates physicians through
95 to identify the risk of new onset functional gastrointestinal disorders (FGD) and gastroesophageal re
96 were identified with one of these functional gastrointestinal disorders (FGDs), compared with 6% of c
99 l framework for understanding the functional gastrointestinal disorders (FGID) from a biopsychosocial
103 ation of childhood and adolescent functional gastrointestinal disorders (FGIDs) has evolved during th
105 ncreasingly used for treatment of functional gastrointestinal disorders (FGIDs), now recognized as di
110 ter database to evaluate the risk of several gastrointestinal disorders following select foodborne in
111 iteria for abdominal pain-related functional gastrointestinal disorders from a single US outpatient g
112 ldren between 0 and 18 years with underlying gastrointestinal disorders had been treated for concomit
113 aser endomicroscopy and in-vivo diagnosis of gastrointestinal disorders has increased in the last few
114 NK) B and NK3 receptors in visceral pain and gastrointestinal disorders has not been determined.
115 the Rome III definition of functional upper gastrointestinal disorders has refined the concept of NE
116 Recent insights in the field of functional gastrointestinal disorders have opened the way for novel
117 The International Foundation for Functional Gastrointestinal Disorders (IFFGD) is a nonprofit educat
118 ndrome (CVS) is a well-recognized functional gastrointestinal disorder in children but its presentati
119 reflux disease (GERD) is the most prevalent gastrointestinal disorder in the United States, and lead
120 classes and symptoms, with the exception of gastrointestinal disorders in 21 (81%) of 23 patients in
121 y no report that describes the prevalence of gastrointestinal disorders in a representative group of
125 al center for the diagnosis and follow-up of gastrointestinal disorders in southern Italy (ie, Bari,
127 e leading cause of admission to hospital for gastrointestinal disorders in the USA and many other cou
128 izing the importance of childhood functional gastrointestinal disorders in understanding adult functi
129 ew treatment strategies for a broad range of gastrointestinal disorders, including constipation, pseu
130 dverse events, mostly of mild severity, were gastrointestinal disorders, including diarrhoea (18 [4%]
131 latory influence of histamine on a number of gastrointestinal disorders, including food allergy, scom
132 ns, these drugs also frequently cause severe gastrointestinal disorders, including mucosal erosions,
133 esity to common and debilitating hepatic and gastrointestinal disorders, including nonalcoholic steat
134 r have potential for treatment of functional gastrointestinal disorders, including psychopharmacologi
139 ication of abdominal pain-related functional gastrointestinal disorders might help to select children
140 ssociated with the development of functional gastrointestinal disorders, most commonly irritable bowe
141 siology and symptom generation of functional gastrointestinal disorders needs to be further studied a
142 bdominal pain (2.48, 1.61-3.81, p<0.0001), a gastrointestinal disorder (non-surgical 2.32, 1.51-3.56,
143 e primary causes can be divided into erosive gastrointestinal disorders, nonerosive gastrointestinal
144 an organic disorder or some other functional gastrointestinal disorder (not related to abdominal pain
147 e events, most commonly minor infections and gastrointestinal disorders, occurred in more than 95% of
149 the treatment or investigation of functional gastrointestinal disorders or disease models need to hav
151 l abuse and lifetime diagnosis of functional gastrointestinal disorders (OR, 2.43; 95% CI, 1.36-4.31;
152 R, 3.27; 95% CI, 1.02-10.53), and functional gastrointestinal disorders (OR, 4.01; 95% CI, 1.88-8.57)
154 al and some clinical data to link functional gastrointestinal disorders pathogenesis to disturbances
155 n recent times, the perception of functional gastrointestinal disorders such as irritable bowel syndr
157 ssment using the patient assessment of upper gastrointestinal disorders-symptom severity index (PAGI-
159 ancreatitis (AP) is a common and devastating gastrointestinal disorder that causes significant morbid
161 to inflammatory bowel disorders, a group of gastrointestinal disorders that can produce serious recu
162 s during disease or injury may underlie many gastrointestinal disorders that currently have unknown e
163 constipation are the most common functional gastrointestinal disorders that lead to referral to a pe
164 thors examine the differential diagnosis for gastrointestinal disorders that should be considered in
165 have been implicated in the pathogenesis of gastrointestinal disorders, their function has not been
166 wel syndrome (IBS), which is the most common gastrointestinal disorder, there may be disturbances at
169 oval of oral GUCY2C ligands to treat chronic gastrointestinal disorders underscores the potential the
170 conference of experts in zinc nutrition and gastrointestinal disorders was convened to consider appr
171 ange of protective effects of Sb in multiple gastrointestinal disorders, we hypothesize that Sb modul
172 ldren with abdominal pain-related functional gastrointestinal disorders were enrolled and assigned to
178 etween-group differences were largely due to gastrointestinal disorders, which were more common with
179 ritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose hallmark is abdominal pa
180 onal constipation is a prevalent, burdensome gastrointestinal disorder whose treatment remains challe
181 well as prognostic and diagnostic tools for gastrointestinal disorders, will be greatly facilitated
182 Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with symptoms of abdominal pai
183 bowel syndrome is classified as a functional gastrointestinal disorder with the primary symptom of ab
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。